Cargando…

Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma

PURPOSE: Mediastinal radiotherapy (RT), especially when combined with bleomycin, may result in substantial pulmonary morbidity and mortality. The use of modern RT techniques like intensity-modulated radiotherapy (IMRT) is gaining interest to spare organs at risk. METHODS: We evaluated 27 patients wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Pepper, Niklas Benedikt, Oertel, Michael, Kittel, Christopher, Kröger, Kai Jannes, Elsayad, Khaled, Haverkamp, Uwe, Eich, Hans Theodor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499413/
https://www.ncbi.nlm.nih.gov/pubmed/32945894
http://dx.doi.org/10.1007/s00066-020-01682-0
_version_ 1783583709781295104
author Pepper, Niklas Benedikt
Oertel, Michael
Kittel, Christopher
Kröger, Kai Jannes
Elsayad, Khaled
Haverkamp, Uwe
Eich, Hans Theodor
author_facet Pepper, Niklas Benedikt
Oertel, Michael
Kittel, Christopher
Kröger, Kai Jannes
Elsayad, Khaled
Haverkamp, Uwe
Eich, Hans Theodor
author_sort Pepper, Niklas Benedikt
collection PubMed
description PURPOSE: Mediastinal radiotherapy (RT), especially when combined with bleomycin, may result in substantial pulmonary morbidity and mortality. The use of modern RT techniques like intensity-modulated radiotherapy (IMRT) is gaining interest to spare organs at risk. METHODS: We evaluated 27 patients who underwent RT for Hodgkin’s lymphoma between 2009 and 2013 at our institution. For each patient, three different treatment plans for a 30-Gy involved-field RT (IFRT) were created (anterior-posterior-posterior-anterior setup [APPA], 5‑field IMRT, and 7‑field IMRT) and analyzed concerning their inherent “normal tissue complication probability” (NTCP) for pneumonitis and secondary pulmonary malignancy. RESULTS: The comparison of different radiation techniques showed a significant difference in favor of standard APPA (p < 0.01). The risk of lung toxicity was significantly higher in plans using 7‑field IMRT than in plans using 5‑field IMRT. The absolute juxtaposition showed an increase in risk for radiation pneumonitis of 1% for plans using 5‑field IMRT over APPA according to QUANTEC (Quantitative Analyses of Normal Tissue Effects in the Clinic) parameters (Burman: 0.15%) and 2.6% when using 7‑field IMRT over APPA (Burman: 0.7%) as well as 1.6% when using 7‑field IMRT over 5‑field IMRT (Burman: 0.6%). Further analysis showed an increase in risk for secondary pulmonary malignancies to be statistically significant (p < 0.01); mean induction probability for pulmonary malignoma was 0.1% higher in plans using 5‑field IMRT than APPA and 0.19% higher in plans using 7‑field IMRT than APPA as well as 0.09% higher in plans using 7‑field IMRT than 5‑field IMRT. During a median follow-up period of 65 months (95% confidence interval: 53.8–76.2 months), only one patient developed radiation-induced pneumonitis. No secondary pulmonary malignancies have been detected to date. CONCLUSION: Radiation-induced lung toxicity is rare after treatment for Hodgkin lymphoma but may be influenced significantly by the RT technique used. In this study, APPA RT plans demonstrated a decrease in potential radiation pneumonitis and pulmonary malignancies. Biological planning using NTCP may have the potential to define personalized RT strategies
format Online
Article
Text
id pubmed-7499413
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-74994132020-09-18 Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma Pepper, Niklas Benedikt Oertel, Michael Kittel, Christopher Kröger, Kai Jannes Elsayad, Khaled Haverkamp, Uwe Eich, Hans Theodor Strahlenther Onkol Original Article PURPOSE: Mediastinal radiotherapy (RT), especially when combined with bleomycin, may result in substantial pulmonary morbidity and mortality. The use of modern RT techniques like intensity-modulated radiotherapy (IMRT) is gaining interest to spare organs at risk. METHODS: We evaluated 27 patients who underwent RT for Hodgkin’s lymphoma between 2009 and 2013 at our institution. For each patient, three different treatment plans for a 30-Gy involved-field RT (IFRT) were created (anterior-posterior-posterior-anterior setup [APPA], 5‑field IMRT, and 7‑field IMRT) and analyzed concerning their inherent “normal tissue complication probability” (NTCP) for pneumonitis and secondary pulmonary malignancy. RESULTS: The comparison of different radiation techniques showed a significant difference in favor of standard APPA (p < 0.01). The risk of lung toxicity was significantly higher in plans using 7‑field IMRT than in plans using 5‑field IMRT. The absolute juxtaposition showed an increase in risk for radiation pneumonitis of 1% for plans using 5‑field IMRT over APPA according to QUANTEC (Quantitative Analyses of Normal Tissue Effects in the Clinic) parameters (Burman: 0.15%) and 2.6% when using 7‑field IMRT over APPA (Burman: 0.7%) as well as 1.6% when using 7‑field IMRT over 5‑field IMRT (Burman: 0.6%). Further analysis showed an increase in risk for secondary pulmonary malignancies to be statistically significant (p < 0.01); mean induction probability for pulmonary malignoma was 0.1% higher in plans using 5‑field IMRT than APPA and 0.19% higher in plans using 7‑field IMRT than APPA as well as 0.09% higher in plans using 7‑field IMRT than 5‑field IMRT. During a median follow-up period of 65 months (95% confidence interval: 53.8–76.2 months), only one patient developed radiation-induced pneumonitis. No secondary pulmonary malignancies have been detected to date. CONCLUSION: Radiation-induced lung toxicity is rare after treatment for Hodgkin lymphoma but may be influenced significantly by the RT technique used. In this study, APPA RT plans demonstrated a decrease in potential radiation pneumonitis and pulmonary malignancies. Biological planning using NTCP may have the potential to define personalized RT strategies Springer Berlin Heidelberg 2020-09-18 2021 /pmc/articles/PMC7499413/ /pubmed/32945894 http://dx.doi.org/10.1007/s00066-020-01682-0 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Pepper, Niklas Benedikt
Oertel, Michael
Kittel, Christopher
Kröger, Kai Jannes
Elsayad, Khaled
Haverkamp, Uwe
Eich, Hans Theodor
Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma
title Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma
title_full Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma
title_fullStr Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma
title_full_unstemmed Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma
title_short Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma
title_sort impact of radiation techniques on lung toxicity in patients with mediastinal hodgkin’s lymphoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499413/
https://www.ncbi.nlm.nih.gov/pubmed/32945894
http://dx.doi.org/10.1007/s00066-020-01682-0
work_keys_str_mv AT pepperniklasbenedikt impactofradiationtechniquesonlungtoxicityinpatientswithmediastinalhodgkinslymphoma
AT oertelmichael impactofradiationtechniquesonlungtoxicityinpatientswithmediastinalhodgkinslymphoma
AT kittelchristopher impactofradiationtechniquesonlungtoxicityinpatientswithmediastinalhodgkinslymphoma
AT krogerkaijannes impactofradiationtechniquesonlungtoxicityinpatientswithmediastinalhodgkinslymphoma
AT elsayadkhaled impactofradiationtechniquesonlungtoxicityinpatientswithmediastinalhodgkinslymphoma
AT haverkampuwe impactofradiationtechniquesonlungtoxicityinpatientswithmediastinalhodgkinslymphoma
AT eichhanstheodor impactofradiationtechniquesonlungtoxicityinpatientswithmediastinalhodgkinslymphoma